Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
M.D. Anderson Cancer Center
Thomas Jefferson University
Pfizer
Thomas Jefferson University
Mayo Clinic
Rutgers, The State University of New Jersey
Ethicon, Inc.
Wake Forest University Health Sciences
Pheon Therapeutics
National Cancer Institute (NCI)
Xemed LLC
Pfizer
Takeda
Ethicon, Inc.
Mayo Clinic
M.D. Anderson Cancer Center
University of Kentucky
Tempus AI
Sanofi
Korea University Guro Hospital
Novartis
Galvanize Therapeutics, Inc.
Washington University School of Medicine
Lyell Immunopharma, Inc.
Formycon AG
Massachusetts General Hospital
NRG Oncology
Vanderbilt-Ingram Cancer Center
ImmunoGenesis
University of Kentucky
Faeth Therapeutics
NextCure, Inc.
Abramson Cancer Center at Penn Medicine
Roswell Park Cancer Institute
Bristol-Myers Squibb
Novartis
Elevation Oncology
Fundación GECP
Checkpoint Therapeutics, Inc.
The University of Hong Kong
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Mayo Clinic
Mirati Therapeutics Inc.
ABM Therapeutics Corporation
Inhibrx Biosciences, Inc
Thunder Bay Regional Health Research Institute